Attached files

file filename
10-K - 10-K - Inotiv, Inc.tv509358_10k.htm
EX-32.2 - EXHIBIT 32.2 - Inotiv, Inc.tv509358_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Inotiv, Inc.tv509358_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Inotiv, Inc.tv509358_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Inotiv, Inc.tv509358_ex31-1.htm
EX-21.1 - EXHIBIT 21.1 - Inotiv, Inc.tv509358_ex21-1.htm
EX-10.19 - EXHIBIT 10.19 - Inotiv, Inc.tv509358_ex10-19.htm
EX-10.18 - EXHIBIT 10.18 - Inotiv, Inc.tv509358_ex10-18.htm
EX-10.17 - EXHIBIT 10.17 - Inotiv, Inc.tv509358_ex10-17.htm
EX-10.15 - EXHIBIT 10.15 - Inotiv, Inc.tv509358_ex10-15.htm
EX-10.14 - EXHIBIT 10.14 - Inotiv, Inc.tv509358_ex10-14.htm

 

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements (No.’s 333-153734 and 333-228747) on Form S-8 of Bioanalytical Systems, Inc. of our report dated December 21, 2018 relating to the consolidated financial statements of Bioanalytical Systems, Inc., appearing in this Annual Report on Form 10-K of Bioanalytical Systems, Inc. for the year ended September 30, 2018.

 

 

/s/ RSM US LLP

 

Indianapolis, Indiana

December 21, 2018